These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1011868)

  • 21. [Observations on the use of endolymphatic chemotherapy in the palliative treatment of malignant tumors in the advanced stage].
    Porzio R
    Minerva Med; 1968 May; 59(42):2474-8. PubMed ID: 4172473
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of Ledacrin on elements of the lobulus in human liver.
    Oleszkiewicz L; Zarzycki J; Szroeder J; Dereń K
    Acta Med Pol; 1979; 20(4):445-6. PubMed ID: 546115
    [No Abstract]   [Full Text] [Related]  

  • 23. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
    Mazerska Z; Lukowicz J; Konopa J
    Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Natural acridine derivatives].
    Johne S; Gröger D
    Pharmazie; 1972 Apr; 27(4):195-208. PubMed ID: 4562545
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical trials referral resource. Clinical trials with pyrazoloacridine.
    Murgo AJ; Cannon D; Christian MC; Cheson B; Nelson AP
    Oncology (Williston Park); 1997 Jul; 11(7):991-4. PubMed ID: 9251119
    [No Abstract]   [Full Text] [Related]  

  • 26. Biochemical studies of cancer patients treated with acridine derivative (C-283). IV. Changes in the levels of serum haptoglobin and sialic acid.
    Dobryszycka W; Osada J; Gerber J; Jablonski K
    Arch Immunol Ther Exp (Warsz); 1973; 21(2):271-9. PubMed ID: 4790848
    [No Abstract]   [Full Text] [Related]  

  • 27. 5-Nitro-4-(N,N-dimethylaminopropylamino)quinoline (5-nitraquine), a new DNA-affinic hypoxic cell radiosensitizer and bioreductive agent: comparison with nitracrine.
    Wilson WR; Siim BG; Denny WA; van Zijl PL; Taylor ML; Chambers DM; Roberts PB
    Radiat Res; 1992 Sep; 131(3):257-65. PubMed ID: 1438685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phase II trial of pyrazoloacridine in patients with persistent or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
    Plaxe SC; Blessing JA; Husseinzadeh N; Webster KD; Rader JS; Dunton CJ
    Gynecol Oncol; 2002 Feb; 84(2):241-4. PubMed ID: 11812081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Niche for acridine derivatives in anticancer therapy.
    Galdino-Pitta MR; Pitta MG; Lima MC; Galdino LS; Pitta RI
    Mini Rev Med Chem; 2013 Jul; 13(9):1256-71. PubMed ID: 22697517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tautomeric equilibrium in nitro-9[(alkylamino)amino]acridines: the role of metal ions and hydrogen bond acceptors.
    Maresca L
    Oftalmologia; 2003; 57(2):89-92. PubMed ID: 12974038
    [No Abstract]   [Full Text] [Related]  

  • 31. Early effect of ledakrin -- a nitro-derivative of acridine -- on cell membrane.
    Popowicz P; Podsiadło H; Knapowski J
    Acta Physiol Pol; 1980; 31(1):81-91. PubMed ID: 6966462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium transport across isolated epithelial structures in vitro--Ledakrin in the liposomes as a moderator of the bioelectric activity of frog skin.
    Rakowski W; Knapowski J
    Acta Physiol Pol; 1983; 34(1):127-37. PubMed ID: 6605665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complexes of nitracrine with DNA. Stoichiometry of binding.
    Szmigiero L; Gniazdowski M
    Arzneimittelforschung; 1981; 31(11):1875-7. PubMed ID: 7198467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intra-arterial infusion chemotherapy: clinical applications and current status of therapeutic effects on various malignant tumors].
    Itsubo M; Kameda H
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):199-206. PubMed ID: 2645833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Place of chemotherapy in the treatment of solid tumors].
    Brule G
    Arq Patol; 1974; 46(2-3):261-6. PubMed ID: 4458638
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of 37 surgical cancers with associated or isolated chemotherapy].
    Montezin J
    Bull Mem Soc Chir Paris; 1971; 61(6):352-68. PubMed ID: 5152093
    [No Abstract]   [Full Text] [Related]  

  • 37. Studies on antitumor and myelotoxic effect of Ledakrin and its selected analogues.
    Glazman-Kuśnierczyk H; Radzikowski C; Budzyński W; Paprocka M
    Arch Immunol Ther Exp (Warsz); 1982; 30(5-6):385-93. PubMed ID: 6191735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Adverse effects of ledakrin and their treatment].
    Pawlicki M; Krawczyk K; Krochmal M
    Nowotwory; 1980; 30(3):265-70. PubMed ID: 7433141
    [No Abstract]   [Full Text] [Related]  

  • 39. [Polychemotherapy of malignant neoplasms].
    Kühböck J
    Wien Z Inn Med; 1972; 53(11):553-7. PubMed ID: 4566665
    [No Abstract]   [Full Text] [Related]  

  • 40. Biochemical blood studies in patients with ovarian carcinoma treated with C-283. 3. Immunoelectrophoresis of serum proteins.
    Dobryszycka W; Gerber J; Jabloński K; Bec I
    Arch Immunol Ther Exp (Warsz); 1972; 20(3):367-73. PubMed ID: 4115628
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.